Andreas Karabis

Vice President, Head of Real World Methods & Evidence Generation Team in EMEA at IQVIA

Amsterdam-Zuidoost, North Holland, Netherlands

About

Experience

  • IQVIA (9 yrs)
    • Vice President, Head of Real World Methods & Evidence Generation Team in EMEA at IQVIA
      Aug 2023 - Present · 2 yrs 11 mos

    • Senior Principal, Head of Real World Methods & Evidence Generation Team in EMEA
      Jan 2020 - Aug 2023 · 3 yrs 8 mos

      Leading a team of 80+ experts on retrospective database studies and health economics. The team is based in 4 main hubs: UK, NL, GR and PT, selling & delivering projects in EMEA, including a) Database studies: intervention effectiveness studies, PAESs, PASSs, treatment pattern research, burden of illness research, and external comparator studies and b) HE studies: lit. reviews; evidence synthesis; economic models; HTA and Global Value Dossiers.

    • Senior Principal - Real World and Analytic Solutions, NEMEA
      Mar 2019 - Dec 2019 · 10 mos

  • (Honorary) Senior Research Associate at UCL
    Mar 2017 - Mar 2022 · 5 yrs 1 mo

    I work with the academic staff of the department on research projects, mainly evidence synthesis and dynamic modeling. As a result of this collaboration, a number of abstracts was published, and events (workshops and webinars) and training programs were organized. This collaboration was formalized by the honorary position.

  • Mapi Group (Utrecht Area, Netherlands)
    • Director - Health Economics & Outcome Research (HEOR)
      Feb 2014 - Jun 2017 · 3 yrs 5 mos

      Managing and coaching a dynamic team of highly skilled professionals (health economists, epidemiologists, statisticians and pharmacists) in the Netherlands, UK, Germany, Sweden, Canada and France. Responsible for the business development, organic growth of the team, providing guidance for projects and networking with experts and centers of excellence. Providing guidance and direct the team in - Conducting systematic literature reviews - Evidence synthesis (including frequentist/Bayesian meta-analysis, ITC, NMA, MAIC) - Developing economic evaluation models - Submissions to HTA or reimbursement authorities - (Global) Value dossier development - In-house training on modeling & evidence synthesis - Communication strategy & scientific manuscript development - Collaboration with research institutions on research & training in modeling and evidence synthesis Leading business development activities of the team Thought Leadership (training, webinars, publications & presentations) Networking/Collaboration with Academic Institutions

    • Associate Director
      Sep 2012 - Jan 2014 · 1 yr 5 mos

      Providing guidance and direct projects teams in · Conducting systematic literature reviews, network meta-analysis, and economic models · Submissions to HTA or reimbursement authorities in Europe Leading Business Development activities Developing project proposals

    • Research Consultant
      Sep 2010 - Sep 2012 · 2 yrs 1 mo

      - Economic models for evaluation of pharmaceuticals and other healthcare technologies. - Indirect treatment comparison, network meta-analysis - Communication of relevant evidence in dossier for submissions to Health Technology Agencies or reimbursement authorities (NICE, SMC, G-BA) - Strategic support regarding evidence generation

  • R&D Project Manager at Pi Medical
    Aug 2007 - Sep 2010 · 3 yrs 2 mos

    Modeling and development of algorithms for radiotherapy treatment planning, used in Nucletron 's products Oncentra Prostate and Oncentra GYN, including: - Dose optimization & Inverse Treatment Planning in brachytherapy ( HIPO and DVHO algorithms) - Interactive DVH curve "shaper" - 3D seed reconstruction (CT images) for LDR brachytherapy

  • Project Manager - Analyst at Exodus
    Sep 2006 - Aug 2007 · 1 yr

    Analysis and modeling of Anti-Money Laundering (AML) modules including: - Customer profiling (KYC, Due diligence) - Transaction and customer scoring - Set of rules based on legislation and recomendations (e.g. FATF) - Word matching for the use of lists of suspects (e.g. Europol) - Workflow (handling of alerts, reporting etc) - Specifications of the interface with the core banking system for MoneyWatch, a system developed for Piraeus Bank. Modeling of portfolio optimization problem in assets securitization procedure and development of the solution algorithm (Simulated Annealing / Mixed Integer Programming) in a software module. The module is used in SecurITize, a software platform for monitoring and servicing of the securitization process. Operating in Piraeus Bank.